FY27 revenue guidance of ₹2,200-2,400 crore
Management expects consolidated revenue between ₹2,200 and ₹2,400 crore for FY27, driven by vanillin volume recovery and blends growth.
Camlin Fine Sciences · forward-looking guidance across the available source record.
Guidance tracker
Management expects consolidated revenue between ₹2,200 and ₹2,400 crore for FY27, driven by vanillin volume recovery and blends growth.
Management targets EBITDA margins of 12-14% for FY27, supported by vanillin margin improvement and cost control.
Blends revenue is expected to cross ₹1,400 crore in FY27, with Winpai and Beta4 turning EBITDA positive.
Management expects vanillin sales volume of 4,000-4,200 MT in FY27, with US volumes of 2,200-2,400 MT.